Healthcare IT Investor Diligence

Home/Healthcare IT Investor Diligence
Healthcare IT Investor Diligence 2016-07-31T11:26:52+00:00

Our firm leads investor diligence for private equity firms, venture capital firms, and strategic investors regarding hospital M&A, health plan M&A, and healthcare IT M&A transactions.

Representative Transactions

To date, we’ve been retained to assist on diligence related to over $4.9 billion in transactions in

  • international Classification of Diseases, version 10 (ICD-10) coding,
  • claims processing,
  • eligibility checks,
  • revenue cycle management
  • electronic health records,
  • eDiscovery,
  • HIPAA and HITECH Act electronic release of information (eROI),
  • Medicare claims processing,
  • genetic testing,
  • electronic data interchange (EDI),
  • HIPAA compliant secure text messaging,
  • HITECH Act and HIPAA compliant provider to provider communications,
  • cloud computing,
  • enterprise access management,
  • single sign on,
  • value based care (ACO),
  • value based care (Medicare Advantage / Medicare Part C),
  • health insurance exchanges,
  • health information exchanges,
  • pharmacy benefit management (PBM) and ePrescribing,
  • clinical data analytics
  • clinical decision support
  • patient engagement
  • acquisitions of provider organizations (hospitals and physician groups, IPAs)
  • acquisitions of insurance firms

Representative Clients

  • $1 billion fund managed by New York private equity firm
  • $2 billion fund managed by London private equity firm with San Francisco office
  • Top 3 Silicon Valley venture capital firm

 

(Visited 73 times, 1 visits today)
Share